CfPA-The Center for Professional Advancement, New Brunswick, NJ
October 30-31, 2017
Who Should Attend? This course is designed to serve the needs of professionals working on Innovator and Biosimilar Protein and Peptide stability during development, for approval, and for postmarketing studies. Because of its comprehensive content, this course will be valuable to personnel in • Stability departments • Research and Development • QA and QC • Regulatory Affairs • Production
Professionals who are involved in planning, conducting, reviewing, supervising, or managing stability testing activities to determine shelf lives and retest dates of pharmaceutical proteins and peptides would benefit greatly from this training.
RAPS - Regulatory Affairs Professional Society This course has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's recertification of their Regulatory Affairs Certification (RAC) upon full completion. Course Description
|
|
Invited Speakers:
|
|
Dr. Pardeep K. Gupta; Professor of Pharmaceutics, Philadelphia College of Pharmacy, University of The Sciences in Philadelphia (USP) |
Dr. Pardeep K. Gupta is a Professor of Pharmaceutics in Philadelphia College of Pharmacy at the University of The Sciences in Philadelphia (USP). He received his B. Pharm. and M. Pharm. (pharmaceutical chemistry) degrees from India. He also received a M.S. degree in medicinal chemistry from USP and his Ph.D. in pharmaceutics from University of Wisconsin. His research interests include delivery of proteins and peptides and study of the interaction of drugs with biomembranes. He has published several articles and has authored several book chapters. His teaching responsibilities include courses in solubility, controlled drug delivery and drug stability at the graduate level. He is on the editorial board of Remington: The Science and Practice of Pharmacy, and is the editor of Pharmaceutical Chemistry and Pharmaceutical Testing, Analysis and Control sections of the book.
|
|